Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$846B
sum of reported positions
Reported positions
626
Changes vs prior quarter
584
70 new · 57 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 325 measured positions in 8 quarters, the typical new or larger position finished −1.3 pts against the S&P 500 and 47% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $733B | $846B |
| Positions | 613 | 626 |
| Biggest line | — | Broadcom 5% |
| 133M |
| $24.1B |
| 2.8% |
| 40.9M | $23B | 2.7% |
| 109M | $21.8B | 2.6% |
| 55.1M | $20.6B | 2.4% |
| 45.7M | $19.2B | 2.3% |
| 15.9M | $19.1B | 2.3% |
| 34.4M | $16.4B | 1.9% |
| 42.5M | $15B | 1.8% |
| 61.2M | $14.6B | 1.7% |
| 45.3M | $13.7B | 1.6% |
| 26.1M | $13B | 1.5% |
| 29.9M | $12.4B | 1.5% |
| 39.3M | $11.4B | 1.3% |
| 16.6M | $10.6B | 1.3% |
| 29.1M | $10.5B | 1.2% |
| 28.3M | $9.7B | 1.1% |
| 91.5M | $9.35B | 1.1% |
| 218M | $8.62B | 1.0% |
| 75M | $7.75B | 0.9% |
| 55.2M | $7.71B | 0.9% |
| 3.73M | $7.41B | 0.9% |
| 27.1M | $7.38B | 0.9% |
Smurfit Westrock (SW)
12.5M → 15.5M shares (+24%)
Bloom Energy (BE)
1.84M → 2.34M shares (+28%)
Lpl Financial (LPLA)
2.31M → 2.34M shares (+1%)
Beone Medicines (ONC)
1.62M → 2.25M shares (+39%)
American International Group (AIG)
8M → 8.56M shares (+7%)
Hershey Company (The) (HSY)
2.75M → 3.5M shares (+27%)
MKS Instruments (MKSI)
1.28M → 1.37M shares (+7%)
Brookfield Asset Management (BAM)
10.5M → 13.5M shares (+28%)
Sempra (SRE)
2.09M → 6.23M shares (+198%)
SPX Technologies (SPXC)
1.75M → 2.34M shares (+34%)
TOPBUILD COR
1.48M → 1.58M shares (+7%)
Crane (CR)
2.39M → 2.49M shares (+4%)
Pfizer (PFE)
21.9M → 22.2M shares (+1%)
Royalty Pharma (RPRX)
8.04M → 9.52M shares (+18%)
Trane Technologies (TT)
1.02M → 1.05M shares (+3%)
RenaissanceRe (RNR)
1.48M → 1.57M shares (+6%)
PETROLEO BRASILEIRO S A
14.1M → 29.4M shares (+109%)
Sunbelt Rentals Holdings (SUNB)
5.69M → 5.93M shares (+4%)
Amphenol (APH)
1.55M → 2.45M shares (+57%)
Dow Inc. (DOW)
7.1M → 15.7M shares (+122%)
TEVA PHARMACEUTICAL INDS LTD
8.83M → 12.5M shares (+42%)
Fortinet (FTNT)
1.61M → 2.74M shares (+71%)
Newamsterdam Pharma Co N.V. (NAMS)
11.1M → 12.2M shares (+10%)
TJX Companies (TJX)
2.4M → 2.7M shares (+13%)
Natera (NTRA)
1.47M → 1.5M shares (+3%)
